Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
Paula RackoffDivision of Rheumatology, Beth Israel Medical Center, New York, NY, USAAbstract: Fragility fractures that occur as a result of osteoporosis are frequently associated with chronic pain and decreased quality of life as well as significant morbidity and mortality. Fracture reduction, howev...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-05-01
|
| Series: | Clinical Interventions in Aging |
| Subjects: | |
| Online Access: | https://www.dovepress.com/efficacy-and-safety-of-risedronate-150-mg-once-a-month-in-the-treatmen-peer-reviewed-article-CIA |